In-vitro Cytotoxicity Assay of Quinoxalines

Major objective of work is in-vitro cytotoxicity assay of newly synthesized compounds and estimated deaths due to the cancer in human beings in US. Current manuscript also provides the chemotherapy of cancer with highly active and safe anti-cancer synthesized quinoxaline compounds and their in-vitro assay at National Cancer Institute (NCI). A series of new quinoxaline derivatives 3 (a-h) has been prepared. The newly synthesized compounds were further evaluated in the National Cancer Institute for their in-vitro cytotoxicity assay. Among them compound 3h has been show highest activity against Leukemia RPMI-8226 cell lines (GI50: 1.11 μM) as compared to other tested compounds. It is to be noted that compound 3e has been show significant activity against cancer cell lines. (GI50: 1.11 μM). We conclude that the ongoing studies of targeted agents in conjunction with chemotherapy will show whether there are alternative option for new and safer medicine for cancer in future as well as opens the new doors in era of cancer research. .